Rockeby signs HK distributor
Monday, 12 January, 2004
Recently floated diagnostics company Rockeby Biomed (ASX:RBY) has signed up Asia-Pacific healthcare and pharmaceutical distributor JDH Healthcare as its exclusive distributor for its Candia5 Rapid Test kit in Hong Kong and Macau.
The unique test for vaginal candidiasis (thrush) -- a disease that affects 75 per cent of women at least once in their lifetime -- will be initially marketed there as a point of care test available from general practitioners, gynaecologists and obstetricians.
It has already been launched in several other Asia-Pacific markets including Australia, New Zealand, Singapore and Malaysia.
The Singapore- and Australia-based company listed on the ASX on December 23rd at AUD$0.20 and at the time of writing was trading at $0.245.
How brain cells are affected by Tourette syndrome
US researchers have conducted a cell-by-cell analysis of brain tissue from individuals with...
Preventing neural graft rejection in Parkinson's patients
Researchers have engineered a way to fool the immune system into accepting neural grafts as part...
Retinal health linked to dementia risk, study shows
Researchers have discovered that the blood vessels at the back of the eye — called retinal...
